In 72/93 (77.4%) patients with arthritis flare, the joint involvement pattern was similar to that observed prior to TNFα inhibitor discontinuation, affecting joints previously involved; in 21/93 (22.6%) patients, at least one newly affected joint was observed at flare. The gene discussed is TNF; the disease is arthritic joint disease.